Ocular Therapeutix (OCUL) Other Non-Current Assets (2013 - 2026)

Ocular Therapeutix's Other Non-Current Assets history runs 14 years deep, the most recent figure standing at $1.6 million for Q1 2026.

• On a quarterly basis, Other Non-Current Assets changed 0.0% year-over-year to $1.6 million in Q1 2026; TTM through Mar 2026 was $1.6 million, a 0.0% change from a year earlier, with the FY2025 full-year figure at $1.6 million, changed 0.0% from the prior year.
• Other Non-Current Assets was little changed at $1.6 million in Q1 2026 per OCUL's latest filing, from $1.6 million in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $1.8 million in Q1 2022 and bottomed at $1.6 million in Q4 2023.
• The 5-year median for Other Non-Current Assets is $1.6 million (2023), against an average of $1.7 million.
• Across the five-year window, Other Non-Current Assets changed 0.0% in 2022 and dropped 8.5% in 2023, its largest moves.
• Year by year, Other Non-Current Assets stood at $1.8 million in 2022, then fell by 8.5% to $1.6 million in 2023, then changed by 0.0% to $1.6 million in 2024, then changed by 0.0% to $1.6 million in 2025, then changed by 0.0% to $1.6 million in 2026.
• Per Business Quant, the three latest OCUL Other Non-Current Assets figures stand at $1.6 million (Q1 2026), $1.6 million (Q4 2025), and $1.6 million (Q3 2025).